American Century Companies Inc Simulations Plus, Inc. Transaction History

American Century Companies Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$37.48 - $44.74 $26,385 - $31,496	704 Added 6.24%	11,994 $493,000
Q4 2023 Feb 13, 2024	BUY	$33.36 - $45.71 $376,634 - $516,065	11,290 New	11,290 $505,000
Q4 2020 Feb 12, 2021	SELL	$53.26 - $77.18 $269,868 - $391,071	-5,067 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$57.51 - $75.36 $61,075 - $80,032	1,062 Added 26.52%	5,067 $382,000
Q2 2020 Aug 13, 2020	BUY	$32.91 - $59.82 $131,804 - $239,579	4,005 New	4,005 $240,000
Q1 2020 May 14, 2020	SELL	$26.79 - $38.99 $1.19 Million - $1.73 Million	-44,243 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$29.07 - $35.63 $21,918 - $26,865	754 Added 1.73%	44,243 $1.29 Million
Q3 2019 Nov 13, 2019	BUY	$28.19 - $41.75 $1.23 Million - $1.82 Million	43,489 New	43,489 $1.51 Million

175

15.1M

5.4K

1.4K

Ticker SLP
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 20,297,700
Market Cap $584M
Description
Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through four segments: Simulations Plus, Cognigen, DILIsym, and Lixoft. The company offers GastroPlus, which sim...

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

Stay updated on American Century Companies Inc with notifications on news.